{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:17:07Z","timestamp":1790630227007,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Doctoral Scientific Research Foundation of Xinxiang Medical University","award":["No. 505117"],"award-info":[{"award-number":["No. 505117"]}]},{"name":"the Science and technology project of Henan Province","award":["No. 222102310513"],"award-info":[{"award-number":["No. 222102310513"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46696-3","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:33:18Z","timestamp":1774845198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MiR-362-3p inhibits the proliferation, migration and EMT of gastric cancer cells by regulating the DEP-1\/ERK signaling pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Fei","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiesuo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"46696_CR1","doi-asserted-by":"crossref","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. May-Jun ; 74(3):229\u2013263 (2024).","DOI":"10.3322\/caac.21834"},{"issue":"7","key":"46696_CR2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao, W., Chen, H. D., Yu, Y. W., Li, N. & Chen, W. Q. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin. Med. J. (Engl). 134 (7), 783\u2013791 (2021).","journal-title":"Chin. Med. J. (Engl)"},{"issue":"7","key":"46696_CR3","first-page":"707","volume":"16","author":"SMM Alavi Dana","year":"2023","unstructured":"Alavi Dana, S. M. M. et al. Chrysin Effect Against Gastric Cancer: Focus on its Molecular Mechanisms. Curr. Mol. Pharmacol. 16 (7), 707\u2013711 (2023).","journal-title":"Curr. Mol. Pharmacol."},{"issue":"5","key":"46696_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2174\/1389202918666170329110021","volume":"18","author":"MV Nemtsova","year":"2017","unstructured":"Nemtsova, M. V. et al. Implication of Gastric Cancer Molecular Genetic Markers in Surgical Practice. Curr. Genomics. 18 (5), 408\u2013415 (2017).","journal-title":"Curr. Genomics"},{"issue":"4","key":"46696_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.2174\/0929866530666230308145835","volume":"30","author":"Q Guo","year":"2023","unstructured":"Guo, Q., Ding, X., Lv, F., Wang, A. & Wang, J. circ_0006089 Facilitates Gastric Cancer Progression via Decoying miR- 515-5p and Up-regulating CXCL6. Protein Pept. Lett. 30 (4), 314\u2013324 (2023).","journal-title":"Protein Pept. Lett."},{"issue":"11","key":"46696_CR6","doi-asserted-by":"publisher","first-page":"966","DOI":"10.2174\/0109298665265642231020043809","volume":"30","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. MicroRNA3650 Promotes Gastric Cancer Proliferation and Migration through the PTEN\/PI3K-AKT-mTOR and Hippo Pathways. Protein Pept. Lett. 30 (11), 966\u2013973 (2023).","journal-title":"Protein Pept. Lett."},{"issue":"2","key":"46696_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136 (2), 215\u2013233 (2009).","journal-title":"Cell"},{"issue":"13","key":"46696_CR8","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","volume":"76","author":"AA Svoronos","year":"2016","unstructured":"Svoronos, A. A., Engelman, D. M. & Slack, F. J. OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer. Cancer Res. 76 (13), 3666\u20133670 (2016).","journal-title":"Cancer Res."},{"issue":"1","key":"46696_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41467-018-08225-3","volume":"10","author":"W Tang","year":"2019","unstructured":"Tang, W. et al. The p300\/YY1\/miR-500a-5p\/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer. Nat. Commun. 10 (1), 663 (2019).","journal-title":"Nat. Commun."},{"issue":"1","key":"46696_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13048-020-00760-2","volume":"14","author":"S Cao","year":"2021","unstructured":"Cao, S., Li, N. & Liao, X. miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer. J. Ovarian Res. 14 (1), 23 (2021).","journal-title":"J. Ovarian Res."},{"key":"46696_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fcell.2020.00297","volume":"8","author":"H Zhu","year":"2020","unstructured":"Zhu, H., Wang, S., Shen, H., Zheng, X. & Xu, X. SP1\/AKT\/FOXO3 Signaling Is Involved in miR-362-3p-Mediated Inhibition of Cell-Cycle Pathway and EMT Progression in Renal Cell Carcinoma. Front. Cell. Dev. Biol. 8, 297 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"1","key":"46696_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ijc.28010","volume":"133","author":"LL Christensen","year":"2013","unstructured":"Christensen, L. L. et al. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer. Int. J. Cancer. 133 (1), 67\u201378 (2013).","journal-title":"Int. J. Cancer"},{"issue":"8","key":"46696_CR13","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1111\/cas.14101","volume":"110","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Interaction of transforming growth factor-\u03b2-Smads\/microRNA-362-3p\/CD82 mediated by M2 macrophages promotes the process of epithelial-mesenchymal transition in hepatocellular carcinoma cells. Cancer Sci. 110 (8), 2507\u20132519 (2019).","journal-title":"Cancer Sci."},{"issue":"21","key":"46696_CR14","doi-asserted-by":"publisher","first-page":"9680","DOI":"10.1073\/pnas.91.21.9680","volume":"91","author":"A Ostman","year":"1994","unstructured":"Ostman, A., Yang, Q. & Tonks, N. K. Expression of DEP-1, a receptor-like protein- tyrosine-phosphatase, is enhanced with increasing cell density. Proc. Natl. Acad. Sci. USA. 91 (21), 9680\u20139684 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"46696_CR15","doi-asserted-by":"publisher","first-page":"e40742","DOI":"10.1371\/journal.pone.0040742","volume":"7","author":"CE Smart","year":"2012","unstructured":"Smart, C. E. et al. Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. PLoS One. 7 (7), e40742 (2012).","journal-title":"PLoS One"},{"issue":"4","key":"46696_CR16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1083\/jcb.200209019","volume":"161","author":"M Grazia Lampugnani","year":"2003","unstructured":"Grazia Lampugnani, M. et al. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1\/CD148. J. Cell. Biol. 161 (4), 793\u2013804 (2003).","journal-title":"J. Cell. Biol."},{"issue":"18","key":"46696_CR17","first-page":"4236","volume":"56","author":"MM Keane","year":"1996","unstructured":"Keane, M. M., Lowrey, G. A., Ettenberg, S. A., Dayton, M. A. & Lipkowitz, S. The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. Cancer Res. 56 (18), 4236\u20134243 (1996).","journal-title":"Cancer Res."},{"issue":"47","key":"46696_CR18","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1038\/sj.onc.1209647","volume":"25","author":"KK Balavenkatraman","year":"2006","unstructured":"Balavenkatraman, K. K. et al. DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients. Oncogene 25 (47), 6319\u20136324 (2006).","journal-title":"Oncogene"},{"issue":"11","key":"46696_CR19","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/carcin\/bgh224","volume":"25","author":"F Trapasso","year":"2004","unstructured":"Trapasso, F. et al. Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo. Carcinogenesis 25 (11), 2107\u20132114 (2004).","journal-title":"Carcinogenesis"},{"issue":"1","key":"46696_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1128\/MCB.01374-08","volume":"29","author":"C Chabot","year":"2009","unstructured":"Chabot, C., Spring, K., Gratton, J. P., Elchebly, M. & Royal, I. New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival. Mol. Cell. Biol. 29 (1), 241\u2013253 (2009).","journal-title":"Mol. Cell. Biol."},{"issue":"44","key":"46696_CR21","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1038\/onc.2015.9","volume":"34","author":"K Spring","year":"2015","unstructured":"Spring, K. et al. The protein tyrosine phosphatase DEP-1\/PTPRJ promotes breast cancer cell invasion and metastasis. Oncogene 34 (44), 5536\u20135547 (2015).","journal-title":"Oncogene"},{"issue":"8","key":"46696_CR22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"J Hayes","year":"2014","unstructured":"Hayes, J., Peruzzi, P. P. & Lawler, S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol. Med. 20 (8), 460\u2013469 (2014).","journal-title":"Trends Mol. Med."},{"issue":"12","key":"46696_CR23","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrc3166","volume":"11","author":"AL Kasinski","year":"2011","unstructured":"Kasinski, A. L. & Slack, F. J. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat. Rev. Cancer. 11 (12), 849\u2013864 (2011).","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"46696_CR24","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nrm1644","volume":"6","author":"VN Kim","year":"2005","unstructured":"Kim, V. N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell. Biol. 6 (5), 376\u2013385 (2005).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"13","key":"46696_CR25","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2011-12-398040","volume":"120","author":"K Spring","year":"2012","unstructured":"Spring, K. et al. Tyrosine phosphorylation of DEP-1\/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation. Blood 120 (13), 2745\u20132756 (2012).","journal-title":"Blood"},{"issue":"15","key":"46696_CR26","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1182\/blood-2010-09-307694","volume":"117","author":"PM Brunner","year":"2011","unstructured":"Brunner, P. M. et al. Density enhanced phosphatase-1 down-regulates urokinase receptor surface expression in confluent endothelial cells. Blood 117 (15), 4154\u20134161 (2011).","journal-title":"Blood"},{"issue":"3","key":"46696_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1164\/rccm.202008-3100OC","volume":"204","author":"K Tsoyi","year":"2021","unstructured":"Tsoyi, K. et al. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis. Am. J. Respir Crit. Care Med. 204 (3), 312\u2013325 (2021).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"1","key":"46696_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.7150\/ijbs.53795","volume":"17","author":"JC Xu","year":"2021","unstructured":"Xu, J. C. et al. NETO2 promotes esophageal cancer progression by inducing proliferation and metastasis via PI3K\/AKT and ERK pathway. Int. J. Biol. Sci. 17 (1), 259\u2013270 (2021).","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"46696_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-021-01482-9","volume":"21","author":"J Du","year":"2022","unstructured":"Du, J. et al. CircNFIB inhibits tumor growth and metastasis through suppressing MEK1\/ERK signaling in intrahepatic cholangio- carcinoma. Mol. Cancer. 21 (1), 18 (2022).","journal-title":"Mol. Cancer"},{"issue":"1","key":"46696_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13046-019-1156-5","volume":"38","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa\/VEGFR2\/ERK pathway. J. Exp. Clin. Cancer Res. 38 (1), 173 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"46696_CR31","doi-asserted-by":"publisher","first-page":"104100","DOI":"10.1016\/j.ebiom.2022.104100","volume":"81","author":"S Ding","year":"2022","unstructured":"Ding, S. et al. DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway. EBioMedicine 81, 104100 (2022).","journal-title":"EBioMedicine"},{"issue":"16","key":"46696_CR32","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.7150\/ijbs.82606","volume":"19","author":"R Wang","year":"2023","unstructured":"Wang, R. et al. FLOT1 promotes gastric cancer progression and metastasis through BCAR1\/ERK signaling. Int. J. Biol. Sci. 19 (16), 5104\u20135119 (2023).","journal-title":"Int. J. Biol. Sci."},{"issue":"13","key":"46696_CR33","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1038\/onc.2016.352","volume":"36","author":"Q Zhou","year":"2017","unstructured":"Zhou, Q. et al. Transducin (\u03b2)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1\/2 pathway. Oncogene 36 (13), 1873\u20131886 (2017).","journal-title":"Oncogene"},{"issue":"7","key":"46696_CR34","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00277-020-04000-x","volume":"99","author":"Z Cheng","year":"2020","unstructured":"Cheng, Z. et al. A novel NAP1L4\/NUTM1 fusion arising from translocation t(11;15) (p15;q12) in a myeloid neoplasm with eosinophilia and rearrangement of PDGFRA highlights an unusual clinical feature and therapeutic reaction. Ann. Hematol. 99 (7), 1561\u20131564 (2020).","journal-title":"Ann. Hematol."},{"issue":"9","key":"46696_CR35","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1007\/s00277-021-04562-4","volume":"100","author":"L Yin","year":"2021","unstructured":"Yin, L. et al. Novel germline mutation KMT2A G3131S confers genetic susceptibility to familial myeloproliferative neoplasms. Ann. Hematol. 100 (9), 2229\u20132240 (2021).","journal-title":"Ann. Hematol."},{"issue":"7","key":"46696_CR36","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41419-022-05035-w","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. CHST15 gene germline mutation is associated with the development of familial myeloproliferative neoplasms and higher transformation risk. Cell. Death Dis. 13 (7), 586 (2022).","journal-title":"Cell. Death Dis."},{"key":"46696_CR37","doi-asserted-by":"publisher","first-page":"1164692","DOI":"10.3389\/fendo.2023.1164692","volume":"14","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. A bibliometric and visualized research on global trends of immune checkpoint inhibitors related complications in melanoma, 2011\u20132021. Front. Endocrinol. (Lausanne). 14, 1164692 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"46696_CR38","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s12672-025-03068-z","volume":"16","author":"B Li","year":"2025","unstructured":"Li, B., Lin, R., Hua, Y., Ma, B. & Chen, Y. Single\u2013cell RNA sequencing reveals TMEM71 as an immunomodulatory biomarker predicting immune checkpoint blockade response in breast cancer. Discov Oncol. 16 (1), 1256 (2025).","journal-title":"Discov Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46696-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46696-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46696-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:03:02Z","timestamp":1774951382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46696-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46696"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46696-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors have read the manuscript and provided their consent for the submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"10667"}}